6505--Ibuprofen Tablets
ID: 36E79725R0046Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNAC PHARMACEUTICALS (36E797)HINES, IL, 60141, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/2636966affa646b39b35bab389817e64/view
Timeline
    Description

    The Department of Veterans Affairs (VA) is soliciting bids for the provision of ibuprofen tablets as part of its Pharmaceutical Prime Vendor (PPV) Program. This procurement aims to establish a contract for various ibuprofen formulations, requiring bidders to submit pricing for a base year and four one-year options while adhering to specific regulatory and quality standards, including the provision of unique National Drug Codes (NDC) for each product. The contract is crucial for ensuring the availability and consistent quality of pharmaceuticals across multiple government health facilities, emphasizing cost-effectiveness through volume pricing. Interested vendors must submit their offers by July 29, 2025, at 2:30 PM CDT, and can contact Senior Contract Specialist Teresa Hussain at teresa.hussain@va.gov for further information.

    Point(s) of Contact
    Teresa HussainSenior Contract Specialist
    teresa.hussain@va.gov
    Files
    Title
    Posted
    36E79725R0046_1.docx
    The Department of Veterans Affairs (VA) is preparing to issue Request for Proposal (RFP) number 36E79725R0046 for the procurement of Ibuprofen Tablets. This procurement is designated as unrestricted and is intended to supply various VA facilities, including Consolidated Mail Order Pharmacies, State Veterans Homes, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The awarded contract will provide a continuous supply of the medication over a period of one year, with options for four additional one-year periods. Offerors must provide specific branding information and a unique National Drug Code (NDC) for their products. The solicitation is expected to be released electronically around June 3, 2025, with proposals due by June 17, 2025. Interested parties must continuously monitor the Contracting Opportunities website at SAM.gov for updates and should contact the Contract Specialist, Teresa Hussain, for further inquiries. Paper copies of the solicitation will not be provided. This notice underscores the VA's commitment to ensuring a steady supply of essential pharmaceuticals for veterans and other eligible entities.
    36E79725R0046.docx
    The document outlines a solicitation for pharmaceutical products by the Department of Veterans Affairs (VA) under the VA Pharmaceutical Prime Vendor (PPV) Program. It aims to establish a contract for the provision of various ibuprofen formulations, requiring bidders to submit pricing for a base year and four one-year options, including adherence to specific regulatory and quality standards. The solicitation emphasizes the requirement of unique National Drug Codes (NDC) for each product while mandating a 0.5% Cost Recovery Fee included in the pricing. Vendors must maintain compliance with Good Manufacturing Practices and provide commitment letters from manufacturers if they are distributors. The document specifies the roles and responsibilities of bidders, including the need for proper labeling and adherence to the Drug Supply Chain Security Act. The contract duration consists of an implementation period followed by an ordering phase, with the potential for renewal based on performance and regulatory compliance. The overall objective is to ensure the availability and consistent quality of pharmaceuticals for multiple government health facilities, emphasizing cost-effectiveness through volume pricing. This solicitation reflects the VA's commitment to meeting healthcare needs while adhering to federal procurement regulations.
    36E79725R0046 0001.docx
    This document details an amendment issued by the Department of Veterans Affairs (VA) concerning a solicitation for Ibuprofen (Solicitation Number 36E79725R0046). The primary purpose of the amendment is to extend the deadline for receipt of offers from the original date to July 29, 2025, at 2:30 PM CDT. All other terms and conditions within the solicitation remain unchanged despite this adjustment. The document outlines necessary actions for offerors, including the acknowledgment of receipt of the amendment to ensure compliance with the solicitation requirements. The amendment signifies the VA's structured approach to managing procurement timelines while maintaining operational consistency. This type of modification is common in federal procurement processes to ensure that all potential bidders have ample time to prepare and submit competitive proposals.
    Lifecycle
    Title
    Type
    6505--Ibuprofen Tablets
    Currently viewing
    Solicitation
    6505--Ibuprofen Tablets
    Presolicitation
    Similar Opportunities
    6505--Ustekinumab Pens/Syringes or Biosimilar
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Ustekinumab Pens/Syringes or Biosimilars, aimed at supplying various federal health entities including the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract will be awarded for an initial period of one year, with the possibility of four additional one-year option periods, ensuring a consistent supply of these critical pharmaceutical products through the VA and DoD Pharmaceutical Prime Vendor Programs. Offerors must provide drugs with unique National Drug Code (NDC) numbers and ensure that any biosimilar products meet FDA licensing requirements, as outlined in the FDA Purple Book. The solicitation is expected to be released around January 12, 2026, with a tentative closing date of January 27, 2026; interested parties should direct inquiries to Chris Carthron at Christopher.Carthron@va.gov or (708) 786-4980.
    6505--LEVOFLOXICIN 750MG / DEXTROSE 5% 150ML, IVPB (VA-26-00008212)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking small business vendors to supply LEVOFLOXICIN 750MG / DEXTROSE 5% 150ML, IVPB, as part of solicitation number 36C77026Q0005. This procurement involves delivering a total of 1,460 boxes of the pharmaceutical product to the VA CMOP facility in Hines, Illinois, with a base period and four option years, each requiring delivery by January 5th of the respective year. The goods are critical for patient care within the VA healthcare system, emphasizing the importance of timely and compliant delivery. Interested vendors must submit their proposals, including a signed SF 1449, pricing schedule, and other required documentation, by December 16, 2025, at 3 PM Central Time, and can direct inquiries to Contract Specialist Jennifer Coleman at Jennifer.Coleman4@va.gov.
    Ibuprofen 400MG/600MG/800MG Tablets
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Ibuprofen 400MG/600MG/800MG Tablets. The contract will establish a national supply source to provide the items for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. Interested parties should contact Christopher Newman for any questions/comments. The projected solicitation date is March of 2023.
    Pharmaceutical Repackaging Services for National CMOP (770)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for pharmaceutical repackaging services for the National Consolidated Mail Outpatient Pharmacy (CMOP) program. The contract, identified as 36C77026R0004, is a firm-fixed-price, indefinite-delivery agreement intended to support the repackaging of government-purchased oral solid pharmaceuticals into various bottle sizes for distribution to over 7 million veterans. The contract spans a five-year ordering period from February 1, 2026, to January 31, 2031, with a potential six-month extension, and has a minimum value of $20 million and a maximum value of $125 million. Interested contractors should contact Renee Kreutzer at renee.kreutzer@va.gov for further details and must submit their proposals by the specified deadlines, ensuring compliance with all relevant regulations and standards.
    6505--Zonisamide Capsules
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified suppliers for a Firm Fixed Price, Indefinite-Delivery Requirements contract for Zonisamide Capsules in 25mg, 50mg, and 100mg dosages. Offerors are required to provide pricing for a base year and four option years, submit a 0.5% Cost Recovery Fee, and comply with stringent packaging and barcoding standards, including adherence to the Drug Supply Chain Security Act (DSCSA) and National Drug Code (NDC) requirements. These pharmaceutical products are crucial for the healthcare services provided to veterans and military personnel through the VA and DoD Pharmaceutical Prime Vendor Programs. Interested parties should contact Contract Specialist Christopher Carthron at Christopher.Carthron@va.gov for further details, and ensure they meet all compliance and registration requirements, including current SAM registration.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.
    NATIONAL OPERATIONAL/MAILING SUPPLIES
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for operational and mailing supplies through solicitation number 36C77025R0004, aimed at supporting its seven Consolidated Mail Outpatient Pharmacy (CMOP) locations. This procurement involves establishing multiple National Single Award Indefinite Delivery/Indefinite Quantity (IDIQ) contracts for essential items such as corrugated boxes, bubble mailers, sealing tape, and child-resistant medical pouches, ensuring compliance with stringent specifications for patient safety and product integrity. The awarded contracts will facilitate timely deliveries of these supplies, which are critical for the efficient processing and shipment of prescriptions to veterans. Interested vendors must submit their proposals, including product samples and pricing schedules in Excel format, by the extended deadline of January 15, 2026, at 5:00 PM CDT. For further inquiries, contact Kelly L Mann at kelly.mann@va.gov or Kelley Cunningham at kelley.cunningham@va.gov.
    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency, is soliciting quotes for the Pharmacy Uniform Formulary Blanket Purchase Agreement and the Uniform Formulary Additional Discount Program, aimed at establishing an effective pharmacy benefits program for the Military Health System. This procurement involves the evaluation and selection of pharmaceutical agents based on their clinical and cost-effectiveness, with a focus on newly approved drugs that will be reviewed by the Pharmacy and Therapeutics Committee in February 2025. Interested vendors must submit their pricing information, including National Drug Codes (NDCs), by December 19, 2024, and are encouraged to participate in a pre-quotation teleconference on December 4, 2024. For further inquiries, vendors can contact Tracy Banks at tracy.e.banks2.civ@mail.mil or Julia Trang at julia.n.trang.civ@health.mil.
    6505--Biologics by McKesson Specialty Pharmacy (Lenalidomide) (VA-26-00016920)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified suppliers to provide Lenalidomide, a pharmaceutical product, for the Oscar G. Johnson VA Medical Center located in Iron Mountain, MI. This procurement will be conducted through a Brand Name or Equal Request for Quotation (RFQ) under firm-fixed price terms, following FAR Part 13 Simplified Acquisition Procedures. Lenalidomide is crucial for treating certain conditions, making this procurement significant for patient care within the VA system. Interested offerors must submit an itemized quote along with sufficient technical documentation via email to arneil.genus@va.gov by 3 p.m. Central on December 1, 2025, as telephone inquiries will not be accepted.
    VA Direct to Patient supply services
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking small business vendors to provide direct delivery supply services for medical and surgical items to Veteran patients through its Consolidated Mail Outpatient Pharmacy (CMOP) program. The contractor must demonstrate at least two years of experience, the capacity to process approximately 14 million prescriptions annually, and the ability to maintain compliance with federal and state regulations while ensuring a 48-hour average turnaround time for prescription fulfillment. This opportunity is critical for ensuring timely access to essential medical supplies for Veterans, with the contract structured to reimburse vendors per filled prescription at government contract prices, plus handling fees. Interested vendors must submit a capabilities statement to the primary contact, Phillip Reuwer, at Phillip.Reuwer@va.gov by January 11, 2026, with any questions directed to the same contact before January 8, 2026.